These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29933890)

  • 41. Inflammation in ALS/FTD pathogenesis.
    McCauley ME; Baloh RH
    Acta Neuropathol; 2019 May; 137(5):715-730. PubMed ID: 30465257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amyotrophic Lateral Sclerosis: Autoimmune Pathogenic Mechanisms, Clinical Features, and Therapeutic Perspectives.
    Ralli M; Lambiase A; Artico M; de Vincentiis M; Greco A
    Isr Med Assoc J; 2019 Jul; 21(7):438-443. PubMed ID: 31507117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amyotrophic lateral sclerosis: update on clinical management.
    Norris SP; Likanje MN; Andrews JA
    Curr Opin Neurol; 2020 Oct; 33(5):641-648. PubMed ID: 32868602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amyotrophic Lateral Sclerosis Descriptive Epidemiology: The Origin of Geographic Difference.
    Logroscino G; Piccininni M
    Neuroepidemiology; 2019; 52(1-2):93-103. PubMed ID: 30602169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Respiratory Failure in Amyotrophic Lateral Sclerosis.
    Niedermeyer S; Murn M; Choi PJ
    Chest; 2019 Feb; 155(2):401-408. PubMed ID: 29990478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis.
    Thonhoff JR; Simpson EP; Appel SH
    Curr Opin Neurol; 2018 Oct; 31(5):635-639. PubMed ID: 30048339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies.
    Beers DR; Appel SH
    Lancet Neurol; 2019 Feb; 18(2):211-220. PubMed ID: 30663610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amyotrophic lateral sclerosis: a clinical review.
    Masrori P; Van Damme P
    Eur J Neurol; 2020 Oct; 27(10):1918-1929. PubMed ID: 32526057
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of the Complement System by Pentraxins.
    Haapasalo K; Meri S
    Front Immunol; 2019; 10():1750. PubMed ID: 31428091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses.
    Béland LC; Markovinovic A; Jakovac H; De Marchi F; Bilic E; Mazzini L; Kriz J; Munitic I
    Brain Commun; 2020; 2(2):fcaa124. PubMed ID: 33134918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complement in neurological disorders and emerging complement-targeted therapeutics.
    Dalakas MC; Alexopoulos H; Spaeth PJ
    Nat Rev Neurol; 2020 Nov; 16(11):601-617. PubMed ID: 33005040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting the complement system in bacterial meningitis.
    Koelman DLH; Brouwer MC; van de Beek D
    Brain; 2019 Nov; 142(11):3325-3337. PubMed ID: 31373605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical promise of next-generation complement therapeutics.
    Mastellos DC; Ricklin D; Lambris JD
    Nat Rev Drug Discov; 2019 Sep; 18(9):707-729. PubMed ID: 31324874
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial.
    Mora JS; Genge A; Chio A; Estol CJ; Chaverri D; Hernández M; Marín S; Mascias J; Rodriguez GE; Povedano M; Paipa A; Dominguez R; Gamez J; Salvado M; Lunetta C; Ballario C; Riva N; Mandrioli J; Moussy A; Kinet JP; Auclair C; Dubreuil P; Arnold V; Mansfield CD; Hermine O;
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):5-14. PubMed ID: 31280619
    [No Abstract]   [Full Text] [Related]  

  • 55. [Role of secretory C1q protein in the formation and regulation of synapse].
    Yan C; Bai J
    Sheng Li Xue Bao; 2019 Jun; 71(3):471-477. PubMed ID: 31218338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New insights into the immune functions of complement.
    Reis ES; Mastellos DC; Hajishengallis G; Lambris JD
    Nat Rev Immunol; 2019 Aug; 19(8):503-516. PubMed ID: 31048789
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Complement System of Agnathans.
    Matsushita M
    Front Immunol; 2018; 9():1405. PubMed ID: 29967624
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New tricks for an ancient system: Physiological and pathological roles of complement in the CNS.
    Tenner AJ; Stevens B; Woodruff TM
    Mol Immunol; 2018 Oct; 102():3-13. PubMed ID: 29958698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ficolin-1 and ficolin-3 polymorphisms and susceptibility to rheumatoid arthritis.
    Pieczarka C; Andrade FA; Catarino SJ; Lidani KCF; Bavia L; Tizzot R; Skare T; de Messias-Reason IJ
    Autoimmunity; 2020 Nov; 53(7):400-407. PubMed ID: 32820945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating Ficolin-2 and Ficolin-3 Form Heterocomplexes.
    Jarlhelt I; Pilely K; Clausen JB; Skjoedt MO; Bayarri-Olmos R; Garred P
    J Immunol; 2020 Apr; 204(7):1919-1928. PubMed ID: 32094208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.